Structural and Functional Brain Imaging in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia Treated With Chemotherapy: A Systematic Review

Abstract Background The effect of chemotherapy on brain development in long-term survivors of pediatric acute lymphoblastic leukemia (ALL) was systematically reviewed. Methods A systematic search of Pubmed, Scopus, and PsycINFO databases was conducted to identify articles published between January 2000 and February 2020 that implemented magnetic resonance imaging to assess brain structure and function in pediatric ALL survivors (diagnosed younger than 21 years of age). The review included articles that were published on children diagnosed with ALL between 0 and 21 years of age and treated with chemotherapy-only protocols. Articles meeting the inclusion criteria described survivors on average of 5 years or more from diagnosis and were peer-reviewed articles and original studies. Results The search yielded 1975 articles with 23 articles meeting inclusion criteria. The review revealed that survivors had statistically significant alterations in brain anatomy, most commonly a smaller hippocampus and impaired microstructural white matter integrity in frontal brain regions. Survivors also had impaired brain function including lower brain network efficiency and altered resting state connectivity. Survivors also displayed widespread reductions in brain activation (ie, frontal, temporal, parietal brain regions) during cognitive tasks. Conclusion Although the neurotoxic effects of cancer treatment are reduced in the absence of cranial radiation, survivors treated on chemotherapy-only protocols still display long-term alterations in brain structure and function, which contribute to lifelong neurocognitive late effects.

[1]  Y. T. Cheung,et al.  Neuroanatomical abnormalities related to dexamethasone exposure in survivors of childhood acute lymphoblastic leukemia , 2020, Pediatric blood & cancer.

[2]  C. Pui,et al.  Association Between Anesthesia Exposure and Neurocognitive and Neuroimaging Outcomes in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia. , 2019, JAMA oncology.

[3]  Y. T. Cheung,et al.  Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia , 2019, Journal of the National Cancer Institute.

[4]  Kotagiri Ramamohanarao,et al.  Mapping connectomes with diffusion MRI: deterministic or probabilistic tractography? , 2018, Magnetic resonance in medicine.

[5]  Y. T. Cheung,et al.  The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only , 2018, American Journal of Neuroradiology.

[6]  R. D'Hooge,et al.  Brain Connectivity and Cognitive Flexibility in Nonirradiated Adult Survivors of Childhood Leukemia , 2018, Journal of the National Cancer Institute.

[7]  Y. T. Cheung,et al.  Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia , 2018, Brain Connect..

[8]  Celia M. Dong,et al.  Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity , 2018, Molecular Neurobiology.

[9]  Y. T. Cheung,et al.  Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia , 2018, JAMA oncology.

[10]  J. Wachowiak,et al.  Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate , 2018, Leukemia & lymphoma.

[11]  J. Wachowiak,et al.  Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy , 2017, Neuroradiology.

[12]  R. Schachar,et al.  Brain structure, working memory and response inhibition in childhood leukemia survivors , 2016, Brain and behavior.

[13]  Y. T. Cheung,et al.  Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. , 2016, The Lancet. Haematology.

[14]  Y. T. Cheung,et al.  Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Murat Yücel,et al.  Brain development during adolescence: A mixed‐longitudinal investigation of cortical thickness, surface area, and volume , 2016, Human brain mapping.

[16]  Shelli R Kesler,et al.  Atypical Structural Connectome Organization and Cognitive Impairment in Young Survivors of Acute Lymphoblastic Leukemia , 2016, Brain Connect..

[17]  Rachel Churchill,et al.  ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.

[18]  J. Downing,et al.  Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Deo Kumar Srivastava,et al.  Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. , 2014, Brain : a journal of neurology.

[20]  J. Neglia,et al.  The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia , 2014, Psycho-oncology.

[21]  W. Reddick,et al.  Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers , 2014, Pediatric blood & cancer.

[22]  Mohsen Saleh Elalfy,et al.  Neurocognitive Outcome and White Matter Anisotropy in Childhood Acute Lymphoblastic Leukemia Survivors Treated with Different Protocols , 2014, Pediatric hematology and oncology.

[23]  H. Ören,et al.  Assessment of Neuropsychological Late Effects in Survivors of Childhood Leukemia , 2014, Pediatric hematology and oncology.

[24]  K. Helton,et al.  Neurocognitive and Neuroradiologic Central Nervous System Late Effects in Children Treated on Pediatric Oncology Group (POG) P9605 (Standard Risk) and P9201 (Lesser Risk) Acute Lymphoblastic Leukemia Protocols (ACCL0131): A Methotrexate Consequence? A Report From the Children’s Oncology Group , 2014, Journal of pediatric hematology/oncology.

[25]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[26]  F. Plessow,et al.  Impact of Chemotherapy for Childhood Leukemia on Brain Morphology and Function , 2013, PloS one.

[27]  Matthew A. Scoggins,et al.  Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort , 2013, Pediatric blood & cancer.

[28]  M. Badr,et al.  Magnetic resonance imaging of the brain in survivors of childhood acute lymphoblastic leukemia , 2012, Oncology letters.

[29]  Daniel C. Alexander,et al.  NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain , 2012, NeuroImage.

[30]  C. Limoli,et al.  Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy , 2012, Clinical Cancer Research.

[31]  S. Kesler,et al.  Cognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia , 2010, Brain Imaging and Behavior.

[32]  L. Westlye,et al.  Brain maturation in adolescence and young adulthood: regional age-related changes in cortical thickness and white matter volume and microstructure. , 2010, Cerebral cortex.

[33]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[34]  Cheng Cheng,et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. , 2009, The New England journal of medicine.

[35]  J. Pierce,et al.  Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. , 2008, Oncology nursing forum.

[36]  C. Lebel,et al.  Microstructural maturation of the human brain from childhood to adulthood , 2008, NeuroImage.

[37]  K. Ligon,et al.  Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies , 2007, Annals of neurology.

[38]  R. Fulbright,et al.  Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[40]  Bruce Fischl,et al.  Geometrically Accurate Topology-Correction of Cortical Surfaces Using Nonseparating Loops , 2007, IEEE Transactions on Medical Imaging.

[41]  Mark Noble,et al.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo , 2006, Journal of biology.

[42]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[43]  S. Gadau,et al.  Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line. , 2006, Archives italiennes de biologie.

[44]  C. Pui,et al.  Smaller white‐matter volumes are associated with larger deficits in attention and learning among long‐term survivors of acute lymphoblastic leukemia , 2006, Cancer.

[45]  J. Shim,et al.  Effect of Long-Term Hormone Therapy on Telomere Length in Postmenopausal Women , 2005, Yonsei medical journal.

[46]  Karl J. Friston,et al.  Voxel-based morphometry of the human brain: Methods and applications , 2005 .

[47]  H. Möller,et al.  Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects. , 2005, Brain research. Brain research protocols.

[48]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[49]  K. Conklin Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness , 2004, Integrative cancer therapies.

[50]  A. M. Dale,et al.  A hybrid approach to the skull stripping problem in MRI , 2004, NeuroImage.

[51]  Krzysztof Jamroziak,et al.  Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies , 2004, Hematology.

[52]  C. Hulette,et al.  Chemotherapy-induced toxic leukoencephalopathy causes a wide range of symptoms: a series of four autopsies , 2004, Modern Pathology.

[53]  S. Cho,et al.  Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy , 2003, Annals of Hematology.

[54]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[55]  Anders M. Dale,et al.  A hybrid approach to the Skull Stripping problem in MRI , 2001, NeuroImage.

[56]  M. Keshavan,et al.  Sex differences in brain maturation during childhood and adolescence. , 2001, Cerebral cortex.

[57]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[58]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[59]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[61]  W. Earnshaw,et al.  Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.

[62]  Alan C. Evans,et al.  Brain development during childhood and adolescence: a longitudinal MRI study , 1999, Nature Neuroscience.

[63]  Akinori Akaike,et al.  Estradiol protects mesencephalic dopaminergic neurons from oxidative stress‐induced neuronal death , 1998, Journal of neuroscience research.

[64]  A. Kingma,et al.  Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia , 1994, The Lancet.

[65]  V. Gilsanz,et al.  Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. , 1990, The Journal of pediatrics.

[66]  R. Brauner,et al.  Growth and Endocrine Disorders Secondary to Cranial Irradiation , 1989, Pediatric Research.

[67]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[68]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[69]  B. Mazoyer,et al.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases , 2007, Neuroradiology.

[70]  R. Maccormick Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? , 2006, Medical hypotheses.

[71]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[72]  M. Engelhardt,et al.  Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy , 1998, Leukemia.